<DOC>
	<DOC>NCT00701402</DOC>
	<brief_summary>The purpose of this observational study is to describe the time to lipid-lowering drug implementation in the management of dyslipidemic patients, according to the cardiovascular risk level.</brief_summary>
	<brief_title>National Survey on Dyslipidemic Patients</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Hypolipidemic Agents</mesh_term>
	<criteria>Diagnosis of dyslipemia made less than 2 years Treated by a lipidlowering drug Agree to take part in the survey Patient included in a clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>time to lipid-lowering drug implementation</keyword>
	<keyword>dyslipidemic patients</keyword>
</DOC>